These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34311770)

  • 21. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
    Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
    Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases.
    Thiagarajan D; Oparina N; Lundström S; Zubarev R; Sun J; ; Alarcon-Riquelme M; Frostegård J
    Sci Rep; 2020 Jul; 10(1):11010. PubMed ID: 32620913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study.
    Elkan AC; Sjöberg B; Kolsrud B; Ringertz B; Hafström I; Frostegård J
    Arthritis Res Ther; 2008; 10(2):R34. PubMed ID: 18348715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis.
    Widdifield J; Abrahamowicz M; Paterson JM; Huang A; Thorne JC; Pope JE; Kuriya B; Beauchamp ME; Bernatsky S
    J Rheumatol; 2019 May; 46(5):467-474. PubMed ID: 30504508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis.
    Öhman M; Öhman ML; Wållberg-Jonsson S
    Scand J Rheumatol; 2014; 43(4):259-64. PubMed ID: 24689997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.
    Ajeganova S; Humphreys JH; Verheul MK; van Steenbergen HW; van Nies JA; Hafström I; Svensson B; Huizinga TW; Trouw LA; Verstappen SM; van der Helm-van Mil AH
    Ann Rheum Dis; 2016 Nov; 75(11):1924-1932. PubMed ID: 26757747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
    Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
    Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory response.
    Diepenhorst GM; Ciurana CL; Diaz Padilla N; Boekholdt SM; Krijnen PA; Lagrand WK; Niessen HW; Hack CE
    Adv Clin Exp Med; 2012; 21(4):455-67. PubMed ID: 23240451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; Benavente L; Caminal-Montero L; Suárez A
    Rheumatology (Oxford); 2020 Feb; 59(2):407-417. PubMed ID: 31302689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-phosphorylcholine IgM, an Anti-inflammatory Mediator, Predicts Peripheral Vein Graft Failure: A Prospective Observational Study.
    Sobel M; Yagi M; Moreno K; Kohler TR; Tang GL; Wijelath ES; Marshall J; Kenagy RD
    Eur J Vasc Endovasc Surg; 2019 Feb; 57(2):259-266. PubMed ID: 30343000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development.
    Frostegård AG; Su J; Hua X; Vikström M; de Faire U; Frostegård J
    PLoS One; 2014; 9(12):e111764. PubMed ID: 25473948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
    Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
    Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum IL8 is not associated with cardiovascular events but with all-cause mortality.
    Moreno Velásquez I; Gajulapuri A; Leander K; Berglund A; de Faire U; Gigante B
    BMC Cardiovasc Disord; 2019 Feb; 19(1):34. PubMed ID: 30717657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
    Arts EE; Fransen J; den Broeder AA; Popa CD; van Riel PL
    Ann Rheum Dis; 2015 Jun; 74(6):998-1003. PubMed ID: 24458537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.
    Pereira I; Laurindo I; Burlingame R; Anjos L; Viana V; Leon E; Vendramini M; Borba E
    Joint Bone Spine; 2008 Jul; 75(4):416-21. PubMed ID: 18457983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients.
    Spinelli FR; Pecani A; Ciciarello F; Colasanti T; Di Franco M; Miranda F; Conti F; Valesini G; Alessandri C
    BMC Musculoskelet Disord; 2017 May; 18(1):214. PubMed ID: 28545441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis.
    Sattui SE; Rajan M; Lieber SB; Lui G; Sterling M; Curtis JR; Mandl LA; Navarro-Millán I
    Semin Arthritis Rheum; 2021 Feb; 51(1):292-298. PubMed ID: 33433365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls.
    Lourdudoss C; Ajeganova S; Frostegård J
    Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction.
    Rubini Gimenez M; Pagano S; Virzi J; Montecucco F; Twerenbold R; Reichlin T; Wildi K; Grueter D; Jaeger C; Haaf P; Vuilleumier N; Mueller C
    Eur J Clin Invest; 2015 Apr; 45(4):369-79. PubMed ID: 25627775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease.
    Eichinger S; Kyrle PA; Kammer M; Eischer L; Ozsvar Kozma M; Binder CJ
    J Thromb Haemost; 2018 Jan; 16(1):31-35. PubMed ID: 29045005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.